Skip to main content

Advertisement

Table 2 Predicting clinical metabolic syndrome variates from homocysteine, both unadjusted, and adjusted with sex and age

From: Type II diabetes mellitus and hyperhomocysteinemia: a complex interaction

  Homocysteine ≥ 10 Homocysteine ≥ 10 (adjusted) Homocysteine ≥ 15 Homocysteine ≥ 15 (adjusted)
Age ≥ 60 1.405 (1.17–1.69) 0.000294   1.504 (1.28–1.77) 8.81 × 10−7  
Sex = male 2.074 (1.71–2.50) 2.98 × 10−14   1.586 (1.33–1.90) 3.23 × 10−7
DxHL 0.844 (0.70–1.01) 0.0706 0.873 (0.72–1.05) 0.154 0.816 (0.69–0.96) 0.0138 0.833 (0.71–0.98) 0.0286
HDL ≤ 40 (men), 50 (women) 0.952 (0.78–1.16) 0.628 1.014 (0.70–1.24) 0.890 1.085 (0.91–1.29) 0.356 1.151 (0.97–1.37) 0.115
Tg ≥ 200 0.977 (0.80–1.20) 0.826 0.968 (0.79–1.20) 0.764 0.923 (0.77–1.11) 0.390 0.937 (0.78–1.13) 0.491
DxT2DM 0.710 (0.59–0.86) 0.000521 0.698 (0.57–0.85) 0.000368 0.879 (0.74–1.05) 0.151 0.862 (0.72–1.03) 0.103
DxHTN 1.244 (1.03–1.50) 0.0212 1.301 (1.07–1.58) 0.00795 1.468 (1.24–1.74) 6.72 × 10−6 1.479 (1.24–1.76) 9.91 × 10−6
BMI ≥ 30 0.906 (0.75–1.10) 0.310 0.995 (0.82–1.21) 0.957 1.027 (0.87–1.21) 0.755 1.081 (0.91–1.28) 0.373
  1. Each block reports OR (95% CI), and p value